Full Text View
Tabular View
No Study Results Posted
Related Studies
Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
This study has been completed.
Study NCT00002872   Information provided by National Cancer Institute (NCI)

First Received on November 1, 1999.   Last Updated on April 18, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metastatic Cancer
Additional conditions recognized in this trial
Neoplasm Metastasis
Neoplasms
Neoplasms, Second Primary
Pleural Effusion
Pleural Effusion, Malignant
More general conditions related to this trial
Neoplasms by Site
Neoplastic Processes
Pathologic Processes
Pleural Diseases
Pleural Neoplasms
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Interventions listed in this trial
bleomycin sulfate
doxycycline
talc
Additional drug interventions recognized in this trial
Bleomycin
Doxycycline hyclate
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antimalarials
Antineoplastic Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
North Central Cancer Treatment Group


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services